4NZ2 |
Crystal structure of CYP2C9 in complex with an inhibitor |
date |
|
authors | Branden, G., Sjogren, T., Xue, Y. |
compound |
source |
symmetry | |
|
crystal cell |
length a |
length b |
length c |
angle alpha |
angle beta |
angle gamma |
|
|
|
|
|
|
|
method | X-Ray Diffraction | resolution | 2.45 |
ligand | 2QJ, GOL, HEM, SO4
| enzyme |
|
Gene Ontology |
Chain | Function | Process | Component | A, B |
|
|
|
|
Primary reference | Structure-based ligand design to overcome CYP inhibition in drug discovery projects., Branden G, Sjogren T, Schnecke V, Xue Y, Drug Discov Today. 2014 Jul;19(7):905-911. doi: 10.1016/j.drudis.2014.03.012., Epub 2014 Mar 16. PMID:24642031 |